Taner Demirci
- Endocrinology, Diabetes and Metabolism top 10%
- Oncology
- Infectious Diseases
- Pathology and Forensic Medicine
- Nephrology top 10%
- Co-authors
- Erman ÇakalMustafa ÇalışkanTuncay DelibaşıCeyhun VarımMustafa ÖzbekMelia KaraköseMustafa Şahi̇nAhmet Nalbant
- Topics
- COVID-19 Clinical Research Studies (11 papers)Thyroid Disorders and Treatments (8 papers)Parathyroid Disorders and Treatments (6 papers)
- Journals
- SHILAP Revista de lepidopterologíaJournal of Medical VirologyInternational Journal of Clinical Practice
- Partner nations
- TürkiyeUnited KingdomColombia
In The Last Decade
Taner Demirci
47 papers receiving 456 citations
Peers
Comparison fields: 5 of 64
- Endocrinology, Diabetes and Metabolism 146
- Oncology 90
- Infectious Diseases 90
- Pathology and Forensic Medicine 84
- Nephrology 83
Countries citing papers authored by Taner Demirci
This map shows the geographic impact of Taner Demirci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taner Demirci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taner Demirci more than expected).
Fields of papers citing papers by Taner Demirci
This network shows the impact of papers produced by Taner Demirci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taner Demirci. The network helps show where Taner Demirci may publish in the future.
Co-authorship network of co-authors of Taner Demirci
This figure shows the co-authorship network connecting the top 25 collaborators of Taner Demirci. A scholar is included among the top collaborators of Taner Demirci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taner Demirci. Taner Demirci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 3 | |
| 6 | 15 | |
| 7 | 0 | |
| 8 | 5 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | 3 | |
| 12 | 15 | |
| 13 | 3 | |
| 14 | 15 | |
| 15 | 2 | |
| 16 | 4 | |
| 17 | 58 | |
| 18 | 2 | |
| 19 | 5 | |
| 20 | 44 |
About Taner Demirci
Taner Demirci is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Reproductive Medicine, having authored 53 papers that have together received 465 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (11 papers), Thyroid Disorders and Treatments (8 papers) and Parathyroid Disorders and Treatments (6 papers). The work is most often cited by research in Nephrology (83 citations), Endocrinology, Diabetes and Metabolism (146 citations) and Infectious Diseases (90 citations). Taner Demirci has collaborated with scholars based in Türkiye, United Kingdom and Colombia. Frequent co-authors include Erman Çakal, Mustafa Çalışkan, Tuncay Delibaşı, Ceyhun Varım, Mustafa Özbek, Melia Karaköse, Mustafa Şahi̇n, Ahmet Nalbant, Tezcan Kaya and Müyesser Saykı Arslan. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Medical Virology and International Journal of Clinical Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.